Frequency of leg cramps after treatment: never · treating leg cramps in pregnancy
Oral magnesium may leads to higher frequency of leg cramps after treatment: never compared with placebo/no treatment (low certainty).
1 finding from 1 review
Frequency: 50% reduction in number of leg cramps · treating leg cramps in pregnancy
Oral magnesium may leads to higher frequency: 50% reduction in number of leg cramps compared with placebo/no treatment (low certainty).
1 finding from 1 review
Intensity of pain during treatment: mean total scale points The degree of pain was noted in the form, on a scale from 0 to 4 measured over 4 days and nights (0 = no pain, 1 = light pain, 2 = medium pain, 3=strong pain, 4=extreme pain) · treating leg cramps in pregnancy
1 finding from 1 review
At least 50% reduction in pain · treating leg cramps in pregnancy
It is very uncertain whether oral magnesium changes intensity of pain: 50% reduction in pain score 100‐mm visual… compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · treating leg cramps in pregnancy
1 finding from 1 review
Duration of leg cramps: persisting symptoms after night‐time cramps Always · treating leg cramps in pregnancy
Oral magnesium may leads to lower duration of leg cramps: persisting symptoms after night‐time cramps… compared with placebo/no treatment (low certainty).
1 finding from 1 review
Duration of leg cramps: persisting symptoms after night‐time cramps Sometimes · treating leg cramps in pregnancy
It is very uncertain whether oral magnesium changes duration of leg cramps: persisting symptoms after night‐time cramps… compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Composite outcome: symptoms of leg cramps (intensity and frequency) Partial improvement: decrease in intensity and frequency · treating leg cramps in pregnancy
It is very uncertain whether oral magnesium changes composite outcome: symptoms of leg cramps (intensity and frequency)… compared with placebo/no treatment (very low certainty).
1 finding from 1 review
Perinatal death or severe morbidity · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fetal or neonatal mortality · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Caesarean section · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Apgar score less than 7 at 5 minutes · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Low umbilical artery pH (< 7.2 or as defined by trial authors) · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
It is very uncertain whether summary of findings for subcutaneous terbutaline changes umbilical artery pH < 7.2 compared with IV magnesium sulphate (very low certainty).
1 finding from 1 review
Resolution of fetal distress on FHR tracing · women for whom a decision had been made to deliver by caesarean section for suspected fetal distress based on FHR monitoring
It is very uncertain whether summary of findings for subcutaneous terbutaline changes resolution of fetal distress on FHR tracing compared with IV magnesium sulphate (very low certainty).
1 finding from 1 review
Recurrence of convulsions · women with eclampsia
It is very uncertain whether treatment of eclampsia: loading dose alone changes recurrence of convulsion compared with loading dose plus maintenance dose regimen (very low certainty).
1 finding from 1 review
Death of the baby before discharge: perinatal death · women with eclampsia
It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes death of the baby before discharge: perinatal death: lower dose… compared with standard‐dose regimens (very low certainty).
1 finding from 1 review
Maternal death · women with eclampsia
It is very uncertain whether treatment of eclampsia: lower‐dose regimens changes maternal death compared with standard‐dose regimens (very low certainty).
1 finding from 1 review
Other neonatal morbidity · women with eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Recurrence of convulsions · women with eclampsia
It is very uncertain whether treatment of eclampsia: IV maintenance changes recurrence of convulsions compared with standard IM maintenance regimen (very low certainty).
1 finding from 1 review
Severe morbidity · women with eclampsia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found